Objectives: Exposure to arsenic and hexavalent chromium is a major public health concern especially in the developing part of the world and there is paucity of information on reliable treatment modalilities. It is in this regard that this study evaluates the efficacy of methanol leaf extract of (MRV) when used as pretreatment agent against potassium dichromate (KCrO) and sodium arsenite (NaAsO) exposure.
Methods: Swiss albino mice between 7 and 10 weeks old were divided into eight cohorts of five animals each. Treatment groups consisted of a distilled water control, MRV alone (275 mg/kg po daily), KCrO (12.0 mg/kg, single ip injection) +/- MRV pretreatment, NaAsO (2.5 mg/kg, single ip injection) +/- MRV pretreatment, NaAsO + KCrO +/- MRV pretreatment. MRV was given for seven consecutive days, while KCrO and NaAsO were injected on day seven of the experiment. The frequency of micronucleated polychromatic erythrocytes (mPCEs) was determined in bone marrow cells, while aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were assessed in the plasma. Hepatic glutathione (GSH), malondialdehyde (MDA), catalase (CAT) and glutathione-S-transferase (GST) levels were also determined.
Results: The NaAsO and KCrO significantly (p<0.05) increased mPCE formation, AST, ALT, and CAT when compared with the control. Simultaneous exposure to NaAsO and KCrO further increased the levels of the markers. Furthermore, GSH and GST were significantly reduced by NaAsO or KCrO or their combination. Pretreatment with MRV reversed the markers towards that of control.
Conclusions: Methanol extract of may therefore ameliorate NaAsO and KCrO-induced toxicities via reduction of oxidative stress and fortification of anti-oxidant system.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1515/jbcpp-2020-0037 | DOI Listing |
Eur Radiol
November 2024
Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Objectives: Comprehensive evaluation of lower-extremity varicose veins (VVs) in patients with diabetes is crucial for treatment strategizing. The study aims to assess the feasibility of using ferumoxytol-enhanced MR venography (FE-MRV) for lower-extremity venous mapping and the detection of VVs in patients with diabetes.
Materials And Methods: As part of a phase II clinical trial of a generic brand of ferumoxytol, documented patients with diabetes were enrolled and underwent FE-MRV on a 3-Τ MRI system.
Stroke
July 2022
Division of Neurology, Department of Pediatrics, The Hospital for Sick Children, Toronto' Ontario' Canada (R.C., G.d., N.D., D.M., E.P., M.M.).
Background: Neonatal cerebral venous sinus thrombosis (CVST) can lead to brain injury and neurodevelopmental impairments. Previous studies of neonatal CVST have focused on term infants, and studies of preterm infants are lacking. In this study, we examined the clinical and radiological features, treatment and outcome of CVST in preterm infants.
View Article and Find Full Text PDFJ Orthod Sci
January 2022
D.A.P. M. R.V. College and Hospital, Bangalore, Karnataka, India.
Objective: The main objective of this study is to get a wider and clearer idea about the relationship between sella turcica bridging and the type of dental anomalies related to size, shape, number, structure and eruption of teeth.
Materials And Methods: For the present study, 50 pretreatment lateral cephalometric radiographs showing complete sella turcica bridging were retrieved from the 500 existing case records of patients. The control group consisted of 50 pretreatment lateral cephalograms without sella turcica bridging retrieved from the same case records by using simple random sampling.
Ther Adv Med Oncol
November 2021
Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Background: The evolution of therapeutic landscape of human epidermal growth factor receptor-2 (HER2)-positive breast cancer (BC) has led to an unprecedented outcome improvement, even if the optimal sequence strategy is still debated. To address this issue and to provide a picture of the advancement of anti-HER2 treatments, we performed a large, multicenter, retrospective study of HER2-positive BC patients.
Methods: The observational PANHER study included 1,328 HER2-positive advanced BC patients treated with HER2 blocking agents since June 2000 throughout July 2020.
J Basic Clin Physiol Pharmacol
December 2020
Department of Biochemistry, Cancer Research and Molecular Biology Laboratories, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Objectives: Exposure to arsenic and hexavalent chromium is a major public health concern especially in the developing part of the world and there is paucity of information on reliable treatment modalilities. It is in this regard that this study evaluates the efficacy of methanol leaf extract of (MRV) when used as pretreatment agent against potassium dichromate (KCrO) and sodium arsenite (NaAsO) exposure.
Methods: Swiss albino mice between 7 and 10 weeks old were divided into eight cohorts of five animals each.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!